mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.037 |
0.3 |
mRNA |
Nilotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.3 |
mRNA |
Axitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.035 |
0.3 |
mRNA |
Merck60 |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.3 |
mRNA |
apicidin |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.3 |
mRNA |
BRD-K55473186 |
CTRPv2 |
pan-cancer |
AAC |
0.047 |
0.3 |
mRNA |
Bexarotene |
CTRPv2 |
pan-cancer |
AAC |
-0.037 |
0.3 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.036 |
0.3 |
mRNA |
itraconazole |
CTRPv2 |
pan-cancer |
AAC |
-0.039 |
0.3 |
mRNA |
BRD-K48477130 |
CTRPv2 |
pan-cancer |
AAC |
-0.056 |
0.3 |